Rituximab in the treatment of Sjögren's syndrome: Is It the Right or Wrong Drug?

Hendrika Bootsma; Frans G. M. Kroese; Arjan Vissink

doi:10.1002/art.40095

Rituximab in the treatment of Sjögren's syndrome: Is It the Right or Wrong Drug?

Hendrika Bootsma^*, Frans G. M. Kroese, Arjan Vissink

^*Corresponding author for this work

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Editorial › Academic › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	1346-1349
Number of pages	4
Journal	Arthritis & Rheumatology
Volume	69
Issue number	7
DOIs	https://doi.org/10.1002/art.40095
Publication status	Published - Jul-2017

Keywords

CONTROLLED-TRIAL
DISEASE-ACTIVITY
EFFICACY
SAFETY
INDEX
CONSENSUS

Access to Document

10.1002/art.40095

Handle.net

Persistent link

Embargoed Document

Rituximab in the Treatment of Sjogren’s Syndrome
Final publisher's version, 64.3 KB

Cite this

@article{b92c6b8d7f6c421e8f98c779059f6561,

title = "Rituximab in the treatment of Sj{\"o}gren's syndrome: Is It the Right or Wrong Drug?",

keywords = "CONTROLLED-TRIAL, DISEASE-ACTIVITY, EFFICACY, SAFETY, INDEX, CONSENSUS",

author = "Hendrika Bootsma and Kroese, {Frans G. M.} and Arjan Vissink",

year = "2017",

month = jul,

doi = "10.1002/art.40095",

language = "English",

volume = "69",

pages = "1346--1349",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

number = "7",

}

TY - JOUR

T1 - Rituximab in the treatment of Sjögren's syndrome

T2 - Is It the Right or Wrong Drug?

AU - Bootsma, Hendrika

AU - Kroese, Frans G. M.

AU - Vissink, Arjan

PY - 2017/7

Y1 - 2017/7

KW - CONTROLLED-TRIAL

KW - DISEASE-ACTIVITY

KW - EFFICACY

KW - SAFETY

KW - INDEX

KW - CONSENSUS

U2 - 10.1002/art.40095

DO - 10.1002/art.40095

M3 - Editorial

C2 - 28296253

SN - 2326-5191

VL - 69

SP - 1346

EP - 1349

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 7

ER -